KKB Attorney Samantha Hong will be speaking at the ACI 12th (Virtual) Summit on Biosimilars and Innovator Biologics on June 22, 2021. Samantha will interview the FDA Keynote Speaker, Jessica Greenbaum, Regulatory Counsel in the Office of Therapeutic Biologics and Biosimilars at the Center for Drug Evaluation and Research, in a discussion on “Biosimilars and Interchangeable Products: Insights into FDA’s Perspective on Implementation.”
For more information on the session, see here.